Sedation: Clinical Trials

12 trials for Sedation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed. 12 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 112Completed 12
Phase 21Completed 1

Follow Sedation: new trials by email Literature Review of Sedation trials Research Report on Sedation

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole Tablets
HSK3486, voriconazole +HSK3486 - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd162019-12-142020-12-19
A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486
HSK3486, Propofol - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd162019-01-092020-01-09
A Study Evaluating the Mass Balance of [14C]HSK3486 Emulsion Injection in Healthy Adults.
HSK3486 - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd62019-01-062019-10-28
A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules
HSK3486, rifampin , HSK3486 - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd162018-12-142019-08-20
A Study Evaluating Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 and Etomidate for Induction of Anesthesia in Healthy Male Subjects
HSK3486+ etomidate - General Anesthetic, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd252016-11-302019-08-13
A Study Evaluating Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Single IV Dose of HSK3486 Injectable Emulsion in Healthy Subjects.
HSK3486 - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd242016-05-012020-03-03
A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male Subjects
HSK3486 - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd132015-11-102021-01-29
Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Female Subjects.
HSK3486, Propofol - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd252015-04-222019-07-31
A Study Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Subjects.
HSK3486, Propofol, Placebo - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd482014-04-132019-07-26
Bioavailability of Dexmedetomidine After Intranasal Administration
Intravenous dexmedetomidine, Intranasal dexmedetomidine - Sedation
Phase 1CompletedUniversity of Turku72009-03-012010-01-13
Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU
Dexmedetomidine - Pharmacokinetics, Sedation
Phase 1CompletedOrion Corporation, Orion Pharma132008-09-012009-04-21
Clonidine-Remifentanil. Effect of the Combination on Acute Pain and Respiration in Healthy Volunteers
Remifentanil+clonidine - Acute Pain, Respiration
Phase 1 / Phase 2CompletedOslo University Hospital122005-02-012011-07-06

Narrower conditions

Acute Pain (1)  ·  Respiratory Aspiration (1)

Broader conditions

Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)  ·  Signs and Symptoms (1)

Interventions

HSK3486 (8)  ·  Propofol (3)  ·  Clonidine (1)  ·  Dexmedetomidine (1)  ·  Remifentanil (1)  ·  Rifampin (1)

Sponsors

Sichuan Haisco Pharmaceutical Group Co., Ltd (9)  ·  Orion Corporation, Orion Pharma (1)  ·  Oslo University Hospital (1)  ·  University of Turku (1)

Countries

China (4)  ·  Finland (2)  ·  Norway (1)

Top investigators

Jon B Bergmann, Ass. Prof. (1)  ·  Klaus T Olkkola, MD, PhD, Professor (1)  ·  Liyan Miao, PhD (1)  ·  Timo Iirola (1)  ·  Timo Iirola, MD (1)

Results publications

PMID 21318594, PMID 22030215, PMID 32415708, PMID 41836529